• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

China: Media reports on details of development of H7N9 reagent and ELISA test kits

Catbird

Senior Moderator
Machine translation:

"Suzhou enterprise research H7N9 virus will be able to quickly detect

2013-04-09

Suzhou, the two companies recently in the research of the H7N9 avian influenza virus has achieved initial results, respectively, to complete the synthesis of key genes of the H7N9 avian flu virus and developed a test kit, the kit can accurately distinguish between ordinary influenza and the H7N9 avian influenza.

Two state enterprises before the H7N9 avian influenza virus research has achieved initial results, respectively, to complete the synthesis of key genes of the H7N9 avian flu virus and developed a test kit, the kit can accurately distinguish between ordinary influenza and the H7N9 avian influenza. The two companies are located in Suzhou biological nano park.

At 1:00 on April 2 multi Biotechnology Co., Ltd., Suzhou gold intellectualism gene synthesis business head of China Liu Weiqiang received an emergency information from the Chinese Academy of Sciences and the National Center for Disease Control, want gold intellectualism company has mastered the genetic sequence of the H7N9 virus, as soon as possible to come up with the key genes of the virus synthetic gene.

Liu Weiqiang led more than 20 R & D staff in the day of the receipt of the information, continuous overtime developed, after four days and nights, two batches of synthetic genes of the H7N9 virus were to send aircraft north.

Liu Weiqiang told the "First Financial Daily" reporters: "normal gene synthesis requires at least 2-3 weeks of time, this time using only four days to complete the task, the first in the country to complete the synthesis of key genes of the H7N9 avian flu virus." virus gene synthesis is the most basic step, it can be used for the development of the H7N9 virus immunoassay reagents for virus structure and function of the ability to use laboratory data to predict the transmission of the virus, and for the production of recombinant vaccines in the future and lay foundation.

Announced the beginning of the epidemic, Suzhou Jayne biological proceeded to take advantage of more than ten unique H7 subtype-specific antibodies, overtime to develop a broad-spectrum the H7 antigen-enzyme-linked (ELISA) detection kit. Vice president of the company's global market and scientific cooperation Qiu Zhiyong said, the preliminary results of the development have found efficient for Chinese popular H7 virus-specific antibodies, which can distinguish between ordinary influenza and the H7N9 avian influenza. Expected within a week the company will complete the test for clinical and research to provide a fast, efficient and large-scale new tools to detect H7N9 infection.

In the near future, the company will produce the latest national CDC H7 antigen, can be used for the development of the H7N9 antibody detection ELISA kit for the detection and judgment of serum samples for the presence of specific antibodies of H7N9.


Qiu Zhiyong H7N9 around the use of nucleic acid detection kit, generally expensive and complicated to operate, only suitable as a means of confirmed central laboratory at the national or provincial and municipal. The field hospital is an urgent need for a low cost, simple, high-sensitivity detection kit."

xhttp://www.yicai.com/news/2013/04/2611904.html


NOTE:

That last paragraph may explain why Vietnam may have to limit testing of possible cases due to expense. (See http://www.flutrackers.com/forum/showthread.php?p=491439#post491439)
 
Re: China: Media reports on details of development of H7N9 reagent and ELISA test kits

Machine translation:

"Da An Gene production H7N9 detection reagents

2013-04-09

...Fastest will successfully developed and skip the clinical trials link production

Sun Yat-sen Da An Gene Co., Ltd. (Da An Gene, 002,030) insiders confirmed to the Post reporter yesterday, the company is developing the H7N9 avian flu detection kit, fastest will be successfully developed within recent days, and clinical trials will be skipped link directly into volume production.

Yesterday, market sources said, is expected the Tat gene within a week can launch the fluorescent PCR for influenza A H7N9 virus nucleic acid rapid detection kit.

Da An Gene Securities Department, told the Post reporter, said that is true in the development of the H7N9 avian influenza detection reagents. Increasing due to the scope of the H7N9 avian flu, the developed detection reagents without clinical assessment directly into production, speed to market..."
 
Re: China: Media reports on details of development of H7N9 reagent and ELISA test kits

And on the down side it strengthens arguments for a possible financial/market bias element in this I suppose.
 
Back
Top